Recent studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of heart rate-corrected QT interval prolongation and atrial fibrillation in patients with type 2 diabetes. Currently, no data exist regarding the relationship between NAFLD and ventricular arrhythmias in this patient population.
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
Mantovani, Alessandro;Rigamonti, Antonio;Bolzan, Bruna;PERNIGO, MATTEO;BERGAMINI, Corinna;RIGOLON, RICCARDO;PICHIRI, Isabella;ZOPPINI, Giacomo;BONORA, Enzo;TARGHER, Giovanni
2016-01-01
Abstract
Recent studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of heart rate-corrected QT interval prolongation and atrial fibrillation in patients with type 2 diabetes. Currently, no data exist regarding the relationship between NAFLD and ventricular arrhythmias in this patient population.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
NAFLD_Arrhythmias_Diabetes Care 2016.pdf
accesso aperto
Tipologia:
Documento in Pre-print
Licenza:
Accesso ristretto
Dimensione
984.76 kB
Formato
Adobe PDF
|
984.76 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
